Rising for the third straight session, equity benchmark Sensex jumped 178 points on July 3, tracking gains in Reliance Industries, Bharti Airtel and TCS amid buoyancy in global markets.

Regulatory approval to Cadila Healthcare’s Zydus for human trials of a potential COVID-19 vaccine too boosted domestic investor sentiment, traders said.

After touching a high of 36,110.21, the 30-share BSE index settled 177.72 points, or 0.50%, higher at 36,021.42.

The NSE Nifty rose 55.65 points, or 0.53%, to end at 10,607.35.

Bharti Airtel was the top gainer in the Sensex pack, rallying around 4%, followed by Bajaj Auto, TCS, Titan, HCL Tech and Reliance Industries.

On the other hand, IndusInd Bank, Tata Steel and HDFC Bank were among the laggards.

According to traders, domestic indices took cues from Asian peers that followed overnight gains on Wall Street after positive jobs data release in the U.S..

Despite hopes of a COVID-19 vaccine, gains were capped as rising coronavirus cases across the world weighed on the market mood, they added.

Bourses in Shanghai, Hong Kong, Tokyo and Seoul ended on a positive note, while those in Europe opened in the red.

Meanwhile, international oil benchmark Brent crude futures fell 1.69 per cent to $42.41 per barrel.

On the currency front, the rupee appreciated 38 paise to settle at 74.66 against the U.S. dollar.

You have reached your limit for free articles this month.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here